Trials / Completed
CompletedNCT05776446
Clinical Behavior of the Asqelio™ Trifocal Diffractive Intraocular Lens
Retrospective Study on the Clinical Behavior of the Asqelio™ Trifocal Diffractive Intraocular Lens With Follow-up at 3 Months
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- AST Products, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this study was to evaluate distance, intermediate, and near vision in patients who have undergone cataract extraction with bilateral implantation of a new hydrophobic trifocal diffractive intraocular lens (IOL) with a biospheric design, the Asqelio Trifocal IOL (AST Products, Inc., Billerica MA, USA), along with patient-reported outcomes (PRO). For that purpose the clinical information of 50 eyes from 25 patients was retrospectively analyzed 3 months after implantation
Conditions
Timeline
- Start date
- 2022-05-27
- Primary completion
- 2022-06-01
- Completion
- 2022-09-01
- First posted
- 2023-03-20
- Last updated
- 2023-03-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05776446. Inclusion in this directory is not an endorsement.